SCHEMBL6415966

SCHEMBL6415966

[NH]C(=O)c1cc2cc(OCC3CCOCC3)ccc2o1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.44
S1PR3 Q99500 1/20 0.44
ACACB O00763 1/20 0.41
SLC2A1 P11166 1/20 0.41
FLT3 P36888 1/20 0.40
PARP10 Q53GL7 6/20 0.40
PARP15 Q460N3 5/20 0.40
PARP2 Q9UGN5 2/20 0.40
MCHR1 Q99705 1/20 0.39
PRKDC P78527 1/20 0.39
PIM1 P11309 1/20 0.39
KDM4C Q9H3R0 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
HTR3A P46098 1/20 0.38
KCNH2 Q12809 1/20 0.38
XDH P47989 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6415969 0.89 PARP10 (0.47) S1PR1S1PR3ACACBSLC2A1FLT3
SCHEMBL6416577 0.89 PIM1 (0.51) S1PR1S1PR3ACACBSLC2A1FLT3
SCHEMBL6414486 0.81 FLT3 (0.43) ACACBFLT3PIM1SLC6A2SLC6A4
SCHEMBL17338649 0.78 PARP10 (0.52) S1PR1S1PR3FLT3PARP10PARP15
SCHEMBL6421505 0.77 CYP1A2 (0.53)
SCHEMBL6414370 0.76 PIM1 (0.47) S1PR1S1PR3FLT3PARP10PARP15
SCHEMBL6418974 0.75 ITGB3 (0.53) XDH
SCHEMBL15623106 0.74 MAOB (0.53) S1PR1S1PR3FLT3KCNH2
SCHEMBL4809717 0.74 ACACB (0.45) ACACBSLC2A1PARP10PARP15PARP2
SCHEMBL12848659 0.74 MAOB (0.52) S1PR1S1PR3FLT3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005118584-A2 SAFRAMYCIN ANALOGS AS THERAPEUTIC AGENTS IN THE TREATMENT OF CANCER AXYS PHARMACEUTICALS, INC. (US) 2005-12-15 WO disclosed